Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy

August 05, 2019 00:10:52
Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy
Obesity: A Disease
Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy

Aug 05 2019 | 00:10:52

/

Show Notes

Episode Description In our article review podcasts, we have carefully selected recent articles included in the latest version of the OMA Obesity Algorithm.  We then discuss this new science with obesity experts. In this episode, Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, Dipl. ABOM interviews Larry Richardson, MD, MFOMA about a recent publication on progress and challenges in anti-obesity pharmacotherapy. Topics covered include: barriers to the use of anti-obesity medication, new, most promising agents being considered that may come to fruition, and dialoging about the resistance of combination therapy for treating obesity. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org. Episode Guests Article Reviewed

Other Episodes

Episode 0

April 19, 2021 00:35:27
Episode Cover

Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development

In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC,...

Listen

Episode

October 23, 2024 00:17:38
Episode Cover

Episode 103: Article Reviews: Compounded Peptides

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Courtney Younglove, MD, FOMA,...

Listen

Episode

June 26, 2025 00:24:47
Episode Cover

Episode 113: Article Reviews: Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management

In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews David Despain, MSc/MSc, CFS. Our...

Listen